Literature DB >> 11997061

Caspase-1 expression in multiple sclerosis plaques and cultured glial cells.

Xue Ming1, Weiping Li, Yasuhiro Maeda, Benjamin Blumberg, Sumul Raval, Stuart D Cook, Peter C Dowling.   

Abstract

Caspase-1 is responsible for processing inflammatory cytokines and is associated with the induction of apoptosis. Using RT-PCR, we found that caspase-1 mRNA transcripts from frozen brain extracts were significantly elevated in multiple sclerosis (MS) compared to controls. Immunohistochemical staining using a specific antiserum confirmed the marked up regulation of caspase-1 within acute and chronic MS plaques, while little staining was seen in control brains. In addition to the expected caspase-1 expression in microglia and infiltrating perivascular mononuclear cells, we found that cytoplasmic caspase-1 expression was sharply increased in the resident oligodendrocytes of MS lesions. The TUNEL reaction for fragmented DNA co-localized over an occasional caspase-1-expressing cell and large numbers of caspase-1-positive "corpses" were observed within phagocytic macrophages of an acute evolving MS lesion. Studies using an immortalized human oligodendroglial hybrid cell line exposed to cytokine challenge showed that death induction was blocked by the caspase-1-like inhibitor Z-YVAD-fmk, while the caspase-3-like inhibitor Z-DEVD-fmk was less effective. Cellular levels of procaspase-1 were reduced compared to controls in oligodendroglia induced to die by cytokine challenge, as judged by Western immunoblotting. Our results suggest that caspase-1 may play a role in the inflammatory and apoptotic processes associated with MS pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11997061     DOI: 10.1016/s0022-510x(02)00030-8

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  39 in total

1.  Caspase-1 inhibitors from an extremophilic fungus that target specific leukemia cell lines.

Authors:  Andrea A Stierle; Donald B Stierle; Teri Girtsman
Journal:  J Nat Prod       Date:  2012-02-01       Impact factor: 4.050

Review 2.  Complementing the inflammasome.

Authors:  Martha Triantafilou; Timothy R Hughes; Bryan Paul Morgan; Kathy Triantafilou
Journal:  Immunology       Date:  2016-02       Impact factor: 7.397

3.  Caspase-1 and -3 inhibiting drimane sesquiterpenoids from the extremophilic fungus Penicillium solitum.

Authors:  Donald B Stierle; Andrea A Stierle; Teri Girtsman; Kyle McIntyre; Jesse Nichols
Journal:  J Nat Prod       Date:  2012-01-25       Impact factor: 4.050

4.  Central nervous system expression of interferon regulatory factor 1 regulates experimental autoimmune encephalomyelitis.

Authors:  Zhihua Ren; Yan Wang; Duan Tao; David Liebenson; Thomas Liggett; Rajendra Goswami; Dusan Stefoski; Roumen Balabanov
Journal:  J Neuroimmune Pharmacol       Date:  2010-02-23       Impact factor: 4.147

Review 5.  Deregulated inflammasome signaling in disease.

Authors:  Mohamed Lamkanfi; Lieselotte Vande Walle; Thirumala-Devi Kanneganti
Journal:  Immunol Rev       Date:  2011-09       Impact factor: 12.988

6.  Interferon-β therapy against EAE is effective only when development of the disease depends on the NLRP3 inflammasome.

Authors:  Makoto Inoue; Kristi L Williams; Timothy Oliver; Peter Vandenabeele; Jayant V Rajan; Edward A Miao; Mari L Shinohara
Journal:  Sci Signal       Date:  2012-05-22       Impact factor: 8.192

7.  Overexpression of the dominant-negative form of interferon regulatory factor 1 in oligodendrocytes protects against experimental autoimmune encephalomyelitis.

Authors:  Zhihua Ren; Yan Wang; Duan Tao; David Liebenson; Thomas Liggett; Rajendra Goswami; Robert Clarke; Dusan Stefoski; Roumen Balabanov
Journal:  J Neurosci       Date:  2011-06-08       Impact factor: 6.167

Review 8.  Importance of oligodendrocyte protection, BBB breakdown and inflammation for remyelination.

Authors:  Jens Watzlawik; Arthur E Warrington; Moses Rodriguez
Journal:  Expert Rev Neurother       Date:  2010-03       Impact factor: 4.618

Review 9.  Neuroprotective effects of the complement terminal pathway during demyelination: implications for oligodendrocyte survival.

Authors:  Cosmin A Tegla; Cornelia Cudrici; Violeta Rus; Takahiro Ito; Sonia Vlaicu; Anil Singh; Horea Rus
Journal:  J Neuroimmunol       Date:  2009-07-04       Impact factor: 3.478

10.  Macrophages of multiple sclerosis patients display deficient SHP-1 expression and enhanced inflammatory phenotype.

Authors:  George P Christophi; Michael Panos; Chad A Hudson; Rebecca L Christophi; Ross C Gruber; Akos T Mersich; Scott D Blystone; Burk Jubelt; Paul T Massa
Journal:  Lab Invest       Date:  2009-04-27       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.